Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy.

Smith SD, Till BG, Shadman MS, Lynch RC, Cowan AJ, Wu QW, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Shustov A, Cassaday RD, Fromm JR, Gopal AK.

Br J Haematol. 2020 Feb 6. doi: 10.1111/bjh.16494. [Epub ahead of print]

PMID:
32030732
2.

Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Kim A, Stevenson P, Cassaday RD, Soma L, Fromm JR, Gopal AK, Smith SD, Till B, Lynch RC, Ujjani C, Shadman M, Warren EH, Menon M, Russell K, Tseng YD.

Pract Radiat Oncol. 2020 Jan - Feb;10(1):44-52. doi: 10.1016/j.prro.2019.09.013. Epub 2019 Oct 1.

PMID:
31585205
3.

Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy.

Chow VA, Gopal AK, Maloney DG, Turtle CJ, Smith SD, Ujjani CS, Shadman M, Cassaday RD, Till BG, Tseng YD, Warren EH, Shustov AR, Menon MP, Bhark S, Acharya UH, Mullane E, Hannan LM, Voutsinas JM, Gooley TA, Lynch RC.

Am J Hematol. 2019 Aug;94(8):E209-E213. doi: 10.1002/ajh.25505. Epub 2019 May 21. No abstract available.

PMID:
31056762
4.

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.

Cooper JP, Khajaviyan S, Smith SD, Maloney DG, Shustov AR, Warren EH, Soma LA, Lynch RC, Ujjani C, Till B, Halpern AB, Gopal AK, Deeg HJ, Scott BL, Shadman M.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):390-395. doi: 10.1016/j.clml.2019.03.003. Epub 2019 Mar 11.

PMID:
30948330
5.

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

Hirayama AV, Gauthier J, Hay KA, Voutsinas JM, Wu Q, Gooley T, Li D, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Acharya UH, Cassaday RD, Chapuis AG, Dhawale TM, Hendrie PC, Kiem HP, Lynch RC, Ramos J, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ.

Blood. 2019 Apr 25;133(17):1876-1887. doi: 10.1182/blood-2018-11-887067. Epub 2019 Feb 19.

PMID:
30782611
6.

Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL.

Smith SD, Reddy P, Sokolova A, Chow VA, Lynch RC, Shadman MA, Till BG, Shustov AR, Warren EH, Ujjani CS, Menon MP, Tseng YD, Gopal AK.

Am J Hematol. 2019 Apr;94(4):E117-E116. doi: 10.1002/ajh.25411. Epub 2019 Feb 4. No abstract available.

PMID:
30663774
7.

Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma.

Smith SD, Gandhy S, Gopal AK, Reddy P, Shadman M, Till BG, Lynch RC, Kanan S, Cowan A, Low L, Hill BT.

Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):48-52. doi: 10.1016/j.clml.2018.10.006. Epub 2018 Oct 17.

PMID:
30409719
8.

Have we found the right patient population for transplantation in follicular lymphoma?

Lynch RC, Gopal AK.

Cancer. 2018 Jun 15;124(12):2484-2487. doi: 10.1002/cncr.31376. Epub 2018 Apr 12. No abstract available.

9.

Dramatic Response with Single-Agent Ibrutinib in Multiply Relapsed Marginal Zone Lymphoma with MYD88L265P Mutation.

Lynch RC, Advani RH.

Case Rep Oncol. 2017 Sep 12;10(3):813-818. doi: 10.1159/000480292. eCollection 2017 Sep-Dec.

10.

Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Lynch RC, Gratzinger D, Advani RH.

Curr Treat Options Oncol. 2017 Oct;18(10):60. doi: 10.1007/s11864-017-0499-4. No abstract available.

PMID:
28861885
11.

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Lynch RC, Gratzinger D, Advani RH.

Curr Treat Options Oncol. 2017 Jul;18(7):45. doi: 10.1007/s11864-017-0483-z. Review. Erratum in: Curr Treat Options Oncol. 2017 Oct;18(10 ):60.

PMID:
28670664
12.

Plant domestication and the assembly of bacterial and fungal communities associated with strains of the common sunflower, Helianthus annuus.

Leff JW, Lynch RC, Kane NC, Fierer N.

New Phytol. 2017 Apr;214(1):412-423. doi: 10.1111/nph.14323. Epub 2016 Nov 23.

13.

Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests.

McKernan K, Spangler J, Helbert Y, Lynch RC, Devitt-Lee A, Zhang L, Orphe W, Warner J, Foss T, Hudalla CJ, Silva M, Smith DR.

F1000Res. 2016 Oct 7;5:2471. eCollection 2016.

14.

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.

Xiao DY, Luo S, O'Brian K, Sanfilippo KM, Ganti A, Riedell P, Lynch RC, Liu W, Kahl BS, Cashen AF, Fehniger TA, Carson KR.

J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw145. Print 2016 Nov.

15.

Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.

Xiao DY, Luo S, O'Brian K, Ganti A, Riedell P, Sanfilippo KM, Lynch RC, Liu W, Carson KR.

Am J Hematol. 2016 Oct;91(10):1002-7. doi: 10.1002/ajh.24465. Epub 2016 Jul 22.

16.

Risk-Adapted Treatment of Advanced Hodgkin Lymphoma With PET-CT.

Lynch RC, Advani RH.

Am Soc Clin Oncol Educ Book. 2016;35:e376-85. doi: 10.14694/EDBK_159036. Review.

17.

Chemotherapy options for previously untreated acute myeloid leukemia.

Lynch RC, Medeiros BC.

Expert Opin Pharmacother. 2015;16(14):2149-62. doi: 10.1517/14656566.2015.1076795. Review.

PMID:
26364895
18.

Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

O'Brian K, Luo S, Ganti A, Riedell P, Lynch RC, Roop R, Sanfilippo KM, Liu W, Colditz GA, Carson KR.

Leuk Lymphoma. 2016 Feb;57(2):313-319. doi: 10.3109/10428194.2015.1056183. Epub 2015 Jul 25.

19.

Metagenomic evidence for metabolism of trace atmospheric gases by high-elevation desert Actinobacteria.

Lynch RC, Darcy JL, Kane NC, Nemergut DR, Schmidt SK.

Front Microbiol. 2014 Dec 17;5:698. doi: 10.3389/fmicb.2014.00698. eCollection 2014.

20.

A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.

Koo S, Thomas HR, Daniels SD, Lynch RC, Fortier SM, Shea MM, Rearden P, Comolli JC, Baden LR, Marty FM.

Clin Infect Dis. 2014 Dec 15;59(12):1733-40. doi: 10.1093/cid/ciu725. Epub 2014 Oct 22.

21.

Nutrient addition dramatically accelerates microbial community succession.

Knelman JE, Schmidt SK, Lynch RC, Darcy JL, Castle SC, Cleveland CC, Nemergut DR.

PLoS One. 2014 Jul 22;9(7):e102609. doi: 10.1371/journal.pone.0102609. eCollection 2014.

22.

Surveillance imaging for lymphoma: pros and cons.

Lynch RC, Zelenetz AD, Armitage JO, Carson KR.

Am Soc Clin Oncol Educ Book. 2014:e388-95. doi: 10.14694/EdBook_AM.2014.34.e388. Review.

23.

Patterns and processes of microbial community assembly.

Nemergut DR, Schmidt SK, Fukami T, O'Neill SP, Bilinski TM, Stanish LF, Knelman JE, Darcy JL, Lynch RC, Wickey P, Ferrenberg S.

Microbiol Mol Biol Rev. 2013 Sep;77(3):342-56. doi: 10.1128/MMBR.00051-12. Review.

24.

Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.

Issa NC, Koo S, Lynch RC, Gay C, Hammond SP, Baden LR, Ghobrial IM, Finkelman MA, Marty FM.

J Clin Microbiol. 2012 Mar;50(3):1054-6. doi: 10.1128/JCM.06295-11. Epub 2011 Dec 14.

25.

Global distribution of Polaromonas phylotypes--evidence for a highly successful dispersal capacity.

Darcy JL, Lynch RC, King AJ, Robeson MS, Schmidt SK.

PLoS One. 2011;6(8):e23742. doi: 10.1371/journal.pone.0023742. Epub 2011 Aug 29.

26.

Regulation of the angiogenesis inhibitor thrombospondin-1 by the breast cancer susceptibility gene-1 (BRCA1).

Grillo J, DelloRusso C, Lynch RC, Folkman J, Zaslavsky A.

Breast J. 2011 Jul-Aug;17(4):434-5. doi: 10.1111/j.1524-4741.2011.01109.x. Epub 2011 Jun 17. No abstract available.

PMID:
21679271
27.

Biogeography and habitat modelling of high-alpine bacteria.

King AJ, Freeman KR, McCormick KF, Lynch RC, Lozupone C, Knight R, Schmidt SK.

Nat Commun. 2010 Aug 10;1:53. doi: 10.1038/ncomms1055.

PMID:
20975720
28.

Phylogeography of microbial phototrophs in the dry valleys of the high Himalayas and Antarctica.

Schmidt SK, Lynch RC, King AJ, Karki D, Robeson MS, Nagy L, Williams MW, Mitter MS, Freeman KR.

Proc Biol Sci. 2011 Mar 7;278(1706):702-8. doi: 10.1098/rspb.2010.1254. Epub 2010 Sep 8.

29.

Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.

Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J, Italiano JE Jr, Ryeom S.

Blood. 2010 Jun 3;115(22):4605-13. doi: 10.1182/blood-2009-09-242065. Epub 2010 Jan 19.

30.

Evidence that chytrids dominate fungal communities in high-elevation soils.

Freeman KR, Martin AP, Karki D, Lynch RC, Mitter MS, Meyer AF, Longcore JE, Simmons DR, Schmidt SK.

Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18315-20. doi: 10.1073/pnas.0907303106. Epub 2009 Oct 13.

31.

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.

Nature. 2009 Jun 25;459(7250):1126-30. doi: 10.1038/nature08062. Epub 2009 May 20.

32.

Practical limitations of bioresorbable membranes in the prevention of intra-abdominal adhesions.

Lim R, Morrill JM, Lynch RC, Reed KL, Gower AC, Leeman SE, Stucchi AF, Becker JM.

J Gastrointest Surg. 2009 Jan;13(1):35-41; discussion 41-2. doi: 10.1007/s11605-008-0724-3. Epub 2008 Oct 15.

PMID:
18854958
33.

Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.

Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F.

Cancer Cell. 2008 May;13(5):420-31. doi: 10.1016/j.ccr.2008.02.018.

34.

TORC1 is essential for NF1-associated malignancies.

Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, Rioth MJ, McClatchey A, Ryeom S, Cichowski K.

Curr Biol. 2008 Jan 8;18(1):56-62. doi: 10.1016/j.cub.2007.11.066. Epub 2007 Dec 27.

35.

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.

Giuriato S, Ryeom S, Fan AC, Bachireddy P, Lynch RC, Rioth MJ, van Riggelen J, Kopelman AM, Passegué E, Tang F, Folkman J, Felsher DW.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16266-71. Epub 2006 Oct 20.

36.

Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.

Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC.

BMC Immunol. 2004 Sep 15;5:20.

38.
40.

Hemobilia from ruptured intrahepatic artery aneurysm in a patient with juvenile rheumatoid arthritis.

Fudge TL, Lynch RC, Ochsner JL.

J Miss State Med Assoc. 1979 Oct;20(10):219-21. No abstract available.

PMID:
537041
41.

Dermatofibrosarcoma protuberans: a case report.

Chapman JE, Lynch RC, Weaver EN Jr.

J La State Med Soc. 1977 Oct;129(10):235-8. No abstract available.

PMID:
925474
42.

Malignant fibrous histiocytoma.

Hughes JP, Mills NL, Lynch RC, Setze TK.

South Med J. 1975 Oct;68(10):1219-22.

PMID:
170688
43.

Aberrant adrenal cortical tissue with inguinal hernia: a case report.

Berry BE, Lynch RC.

J La State Med Soc. 1972 May;124(5):153-5. No abstract available.

PMID:
5024065
44.

MELENA DUE TO ADENOMA OF THE AMPULLA OF VATER.

KNUDSON RJ, ROSSER RG, LYNCH RC.

Am J Surg. 1964 Dec;108:889-91. No abstract available.

PMID:
14233780
45.

The management of pheochromocytoma.

QUINN RH, LYNCH RC.

SD J Med Pharm. 1958 Nov;11(11):444-6. No abstract available.

PMID:
13602968
46.

Duodenal lipoma.

OCHSNER S, LYNCH RC.

Ochsner Clin Rep. 1957 Jan;3(1):24-9. No abstract available.

PMID:
13407912
47.

Thromboangitis obliterans in women; report of two cases.

POTEETE FH Jr, LYNCH RC.

Surgery. 1956 Feb;39(2):340-6. No abstract available.

PMID:
13298986
48.

Annular pancreas: report of a case.

LYNCH RC, KRESS JW, DAVIS JW.

Am Surg. 1955 Nov;21(11):1137-40. No abstract available.

PMID:
13268868
49.

Carcinoid tumor of transverse colon complicated by gastrocolic fistula: survival following resection.

LYNCH RC, BOESE HL.

Surgery. 1955 Sep;38(3):600-4. No abstract available.

PMID:
13246952
50.

Carcinoma of the cecum; clinical analysis of 33 cases.

LYNCH RC, HUTTON SB, JOHNSON GD.

Am J Gastroenterol. 1955 Jul;24(1):53-60. No abstract available.

PMID:
14387992

Supplemental Content

Loading ...
Support Center